Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer

被引：0
|
作者：
Shuang Liu
Shoujing Zhao
Yang Dong
Tingting Wang
Xiaojia Niu
Lijing Zhao
Guan Wang
机构：
[1] Jilin University,Key Laboratory for Molecular Enzymology and Engineering, National Engineering Laboratory for AIDS Vaccine, The Ministry of Education, School of Life Sciences
[2] Jilin University,Department of Rehabilitation, School of Nursing
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 87卷
关键词：
CUDC-907; Antitumor activity; Combination treatment; VS-5584; Pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：415 / 423
页数：8
相关论文
共 50 条
  • [41] CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
    Xu-hong Fu
    Xiong Zhang
    Hong Yang
    Xiao-wei Xu
    Zong-long Hu
    Juan Yan
    Xing-ling Zheng
    Rong-rui Wei
    Zhu-qing Zhang
    Shi-rui Tang
    Mei-yu Geng
    Xun Huang
    Acta Pharmacologica Sinica, 2019, 40 : 677 - 688
  • [42] Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
    Guerra, Fabiana Selos
    Rodrigues, Daniel Alencar
    Fraga, Carlos Alberto Manssour
    Fernandes, Patricia Dias
    PHARMACEUTICALS, 2021, 14 (05)
  • [43] Dual HDAC and PI3K Inhibitor: A Novel Potential Therapeutic Option in Cushing Disease Comment
    Sharma, S. T.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (02): : E1036 - E1038
  • [44] A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells
    Ischenko, Irene
    Petrenko, Oleksi
    Hayman, Michael J.
    ONCOTARGET, 2015, 6 (18) : 15814 - 15827
  • [45] A novel PI3K/mTOR dual inhibitor XH002 exhibited robust antitumor activity in NSCLC
    Lv, Yuanhao
    Du, Tingting
    Ji, Ming
    Wang, Chunyang
    Lin, Songwen
    Xue, Nina
    Jin, Jing
    Xu, Heng
    Chen, Xiaoguang
    JOURNAL OF DRUG TARGETING, 2019, 27 (04) : 451 - 459
  • [46] CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors
    Grand-Guillaume, Joana
    Mansi, Rosalba
    Gaonkar, Raghuvir H.
    Zanger, Sandra
    Fani, Melpomeni
    Eugster, Philippe J.
    Beck Popovic, Maja
    Grouzmann, Eric
    Abid, Karim
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [47] CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors
    Joana Grand-Guillaume
    Rosalba Mansi
    Raghuvir H. Gaonkar
    Sandra Zanger
    Melpomeni Fani
    Philippe J. Eugster
    Maja Beck Popovic
    Eric Grouzmann
    Karim Abid
    Journal of Translational Medicine, 21 (1)
  • [48] A novel dual PI3Kα/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells
    Zou, Zu-Quan
    Zhang, Xiao-Hong
    Wang, Feng
    Shen, Qi-Jun
    Xu, Jin
    Zhang, Li-Na
    Xing, Wen-Hua
    Zhuo, Ren-Jie
    Li, Duo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 (01) : 97 - 101
  • [49] Enhanced Efficacy of 5-Fluorouracil in Combination with a Dual Histone Deacetylase and Phosphatidylinositide 3-Kinase Inhibitor (CUDC-907) in Colorectal Cancer Cells
    Hamam, Rimi
    Ali, Dalia
    Vishnubalaji, Radhakrishnan
    Alsaaran, Zaid F.
    Chalisserry, Elna Paul
    Alfayez, Musaad
    Aldahmash, Abdullah
    Alajez, Nehad M.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2017, 23 (01): : 34 - 38
  • [50] Phase 1 Trial Testing Single Agent CUDC-907, a Novel, Oral Dual Inhibitor of Histone Deacetylase (HDAC) and PI3K: Initial Assessment of Patients with Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL), Including Double Expressor (DE) Lymphoma
    Younes, Anas
    Berdeja, Jesus G.
    Patel, Manish R.
    Kelly, Kevin R.
    Flinn, Ian W.
    Gerecitano, John F.
    Neelapu, Sattva S.
    Copeland, Amanda R.
    Akins, Amy
    Clancy, Myles
    Ma, Anna
    Sun, Kaiming
    Tian, Ze
    Wang, Jing
    Viner, Jaye
    Oki, Yasuhiro
    BLOOD, 2015, 126 (23)
12345